UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease
Everlywell Announces $175 Million Financing to Expand Consumer Lab Testing and Digital Health Offerings
Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement
Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Data Related to COVID-19 and Cancer
Helix Receives FDA Emergency Use Authorization for the HelixⓇ COVID-19 NGS Test, One of the First Sequencing-Based COVID-19 Tests
NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers
QIAGEN launches new solution, QCI Interpret One, which combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients